| Trial ID: | L0280 |
| Source ID: | NCT00430924
|
| Associated Drug: |
Eplerenone
|
| Title: |
Inhibition of Aldosterone in Patients With Chronic Renal Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic
|
| Interventions: |
DRUG: Eplerenone
|
| Outcome Measures: |
Primary: Proteinuria reduction, bi-monthly | Secondary: Evaluating blood pressure response and hyperkalaemia after aldosterone inhibition., weekly
|
| Sponsor/Collaborators: |
Sponsor: Lene Boesby | Collaborators: Rigshospitalet, Denmark
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
42
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2007-03
|
| Completion Date: |
2009-08
|
| Results First Posted: |
|
| Last Update Posted: |
2012-02-08
|
| Locations: |
Rigshospitalet, Blegdamsvej 9, Copenhagen, DK-2100 Ø, Denmark|Herlev Hospital, Herlev, DK-2730, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00430924
|
